CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2018

Apr 24, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9918L

Omega Diagnostics Group PLC

24 April 2018

Omega Diagnostics Group PLC

("Omega" or the "Company")

PDMR Dealing

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 24 April 2018 that Edward Valente, Group R&D Director of the Company has purchased 124,044 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a price of 14.5 pence per Ordinary Share.

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Edward Valente

2.

Reason for notification

b)

Position / status

Group R&D Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Purchase of Ordinary Shares

GB00B1VCP282

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)	Price(s) £
124,044	0.145

d)

Aggregated information

Aggregated volume Price

Aggregate Volume(s)	Volume weighted average Price) £
124,044	0.145

e)

Date of the transaction

24/04/18

f)

Place of the transaction

LSE

Contacts:

Omega Diagnostics Group PLC	Tel: 01259 763 030
Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/James Thompson (Corporate Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFKQDKABKDBQB